PPID
Basic information
Region (hg38): 4:158709127-158723396
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (48 variants)
- not_provided (4 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPID gene is commonly pathogenic or not. These statistics are base on transcript: NM_000005038.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | |||||
| missense | 46 | 49 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 46 | 4 | 1 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PPID | protein_coding | protein_coding | ENST00000307720 | 10 | 14263 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.93e-9 | 0.417 | 125251 | 0 | 496 | 125747 | 0.00197 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.606 | 171 | 195 | 0.878 | 0.00000967 | 2431 |
| Missense in Polyphen | 68 | 73.514 | 0.925 | 951 | ||
| Synonymous | -1.37 | 83 | 68.5 | 1.21 | 0.00000375 | 663 |
| Loss of Function | 0.973 | 16 | 20.8 | 0.770 | 0.00000101 | 268 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00287 | 0.00287 |
| Ashkenazi Jewish | 0.00456 | 0.00457 |
| East Asian | 0.00870 | 0.00874 |
| Finnish | 0.00116 | 0.00116 |
| European (Non-Finnish) | 0.00121 | 0.00120 |
| Middle Eastern | 0.00870 | 0.00874 |
| South Asian | 0.00147 | 0.00147 |
| Other | 0.00163 | 0.00163 |
dbNSFP
Source:
- Function
- FUNCTION: PPIase that catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and may therefore assist protein folding (PubMed:11350175, PubMed:20676357). Proposed to act as a co-chaperone in HSP90 complexes such as in unligated steroid receptors heterocomplexes. Different co- chaperones seem to compete for association with HSP90 thus establishing distinct HSP90-co-chaperone-receptor complexes with the potential to exert tissue-specific receptor activity control. May have a preference for estrogen receptor complexes and is not found in glucocorticoid receptor complexes. May be involved in cytoplasmic dynein-dependent movement of the receptor from the cytoplasm to the nucleus. May regulate MYB by inhibiting its DNA- binding activity. Involved in regulation of AHR signaling by promoting the formation of the AHR:ARNT dimer; the function is independent of HSP90 but requires the chaperone activity. Involved in regulation of UV radiation-induced apoptosis. Promotes cell viability in anaplastic lymphoma kinase-positive anaplastic large- cell lymphoma (ALK+ ALCL) cell lines. {ECO:0000269|PubMed:11350175, ECO:0000269|PubMed:18708059, ECO:0000269|PubMed:20676357, ECO:0000269|PubMed:22681779, ECO:0000269|PubMed:23220213, ECO:0000269|PubMed:9659917}.;
- Pathway
- Necroptosis - Homo sapiens (human);Cellular senescence - Homo sapiens (human);NO-cGMP-PKG mediated Neuroprotection;Signal Transduction;Signaling by Nuclear Receptors;C-MYB transcription factor network;ESR-mediated signaling
(Consensus)
Recessive Scores
- pRec
- 0.120
Intolerance Scores
- loftool
- 0.880
- rvis_EVS
- 0.77
- rvis_percentile_EVS
- 87.01
Haploinsufficiency Scores
- pHI
- 0.245
- hipred
- N
- hipred_score
- 0.454
- ghis
- 0.427
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.471
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ppid
- Phenotype
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;protein peptidyl-prolyl isomerization;protein folding;apoptotic process;protein transport;viral release from host cell;lipid droplet organization;protein refolding;positive regulation of apoptotic process;positive regulation of viral genome replication;positive regulation of protein secretion;chaperone-mediated protein folding;protein-containing complex assembly;cellular response to UV-A
- Cellular component
- nucleus;nucleoplasm;nucleolus;cytoplasm;cytosol
- Molecular function
- peptidyl-prolyl cis-trans isomerase activity;protein binding;transcription factor binding;cyclosporin A binding;estrogen receptor binding;Hsp70 protein binding;heat shock protein binding;unfolded protein binding;Hsp90 protein binding